Clinical Trial

Comparison Study of Insulin GZR4 With Insulin Degludec

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated August 28, 2025 (before its estimated April 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
In this study, the investigational product will be compared with insulin degludec (Tresiba®) and insulin icodec (Awiqli®). The comparator products are approved for the treatment of T2DM in the European Union.
Trial Details
NCT Number NCT07146347
Lead Sponsor Gan and Lee Pharmaceuticals, USA
Collaborators: Profil Institut für Stoffwechselforschung GmbH
Conditions Type 2 Diabetes
Enrollment 14 participants
Start Date 2025-08-15
Primary Completion 2026-04-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-28